In patients at high CV risk receiving simvastatin, the Myopathy Risk Score predicted statin-related myopathy.
Publication
, Journal Article
Kelsey, MD; Newby, LK
Published in: Ann Intern Med
December 15, 2020
Hopewell JC, Offer A, Haynes R, et al. Independent risk factors for simvastatin-related myopathy and relevance to different types of muscle symptom. Eur Heart J. 2020;41:3336-42. 32702748.
Duke Scholars
Published In
Ann Intern Med
DOI
EISSN
1539-3704
Publication Date
December 15, 2020
Volume
173
Issue
12
Start / End Page
JC71
Location
United States
Related Subject Headings
- Simvastatin
- Risk Factors
- Muscular Diseases
- Muscles
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Humans
- General & Internal Medicine
- 3202 Clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Kelsey, M. D., & Newby, L. K. (2020). In patients at high CV risk receiving simvastatin, the Myopathy Risk Score predicted statin-related myopathy. Ann Intern Med, 173(12), JC71. https://doi.org/10.7326/ACPJ202012150-071
Kelsey, Michelle D., and L Kristin Newby. “In patients at high CV risk receiving simvastatin, the Myopathy Risk Score predicted statin-related myopathy.” Ann Intern Med 173, no. 12 (December 15, 2020): JC71. https://doi.org/10.7326/ACPJ202012150-071.
Kelsey MD, Newby LK. In patients at high CV risk receiving simvastatin, the Myopathy Risk Score predicted statin-related myopathy. Ann Intern Med. 2020 Dec 15;173(12):JC71.
Kelsey, Michelle D., and L. Kristin Newby. “In patients at high CV risk receiving simvastatin, the Myopathy Risk Score predicted statin-related myopathy.” Ann Intern Med, vol. 173, no. 12, Dec. 2020, p. JC71. Pubmed, doi:10.7326/ACPJ202012150-071.
Kelsey MD, Newby LK. In patients at high CV risk receiving simvastatin, the Myopathy Risk Score predicted statin-related myopathy. Ann Intern Med. 2020 Dec 15;173(12):JC71.
Published In
Ann Intern Med
DOI
EISSN
1539-3704
Publication Date
December 15, 2020
Volume
173
Issue
12
Start / End Page
JC71
Location
United States
Related Subject Headings
- Simvastatin
- Risk Factors
- Muscular Diseases
- Muscles
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Humans
- General & Internal Medicine
- 3202 Clinical sciences
- 11 Medical and Health Sciences